168
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Ncapg Is A Prognostic Biomarker of Immune Infiltration in Non-Small-Cell Lung Cancer

, , , , , & ORCID Icon show all
Pages 523-535 | Received 12 Dec 2021, Accepted 08 Feb 2022, Published online: 24 Feb 2022

References

  • Siegel RL , MillerKD, JemalA. Cancer statistics, 2017. CA Cancer J. Clin.67(1), 7–30 (2017).
  • Cao M , ChenW. Epidemiology of lung cancer in China. Thorac. Cancer10(1), 3–7 (2019).
  • Blum A , WangP, ZenklusenJC. SnapShot: TCGA-analyzed tumors. Cell173(2), 530 (2018).
  • Arai T , OkatoA, YamadaYet al. Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC. Cancer Med.7(5), 1988–2002 (2018).
  • Dong M , XuT, CuiX, LiH, LiX, XiaW. NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer. Oncol. Lett.21(4), 323 (2021).
  • Gong C , AiJ, FanYet al. NCAPG promotes the proliferation of hepatocellular carcinoma through PI3K/Akt signaling. Onco Targets Ther.12, 8537–8552 (2019).
  • Xiao C , GongJ, JieYet al. NCAPG Is a promising therapeutic target across different tumor types. Front Pharmacol. 11, 387 (2020).
  • Jiang L , RenL, ChenHet al. NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer. Cell Death Dis.11(7), 547 (2020).
  • Lee SS , CheahYK. The interplay between microRNAs and cellular components of tumour microenvironment (TME) on non-small-cell lung cancer (NSCLC) progression. J. Immunol. Res.2019, 3046379 (2019).
  • Liu Z , NingZ, LuHet al. Long non-coding RNA RFPL3S is a novel prognostic biomarker in lung cancer. Oncol Lett.20(2), 1270–1280 (2020).
  • Geng Q , ShenZ, LiL, ZhaoJ. COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer. PeerJ9, e11145 (2021).
  • Guo ZY , ZhuZT. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 25(23), 7238–7251 (2021).
  • Sun DP , LinCC, HungSTet al. Aberrant expression of NCAPG is associated with prognosis and progression of gastric cancer. Cancer Manag. Res.12, 7837–7846 (2020).
  • Song B , DuJ, SongDF, RenJC, FengY. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer. Biol. Res.51(1), 44 (2018).
  • Wu Y , LinY, PanJet al. NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway. Cancer Cell Int.21(1), 443 (2021).
  • Liu C , YanY, DiF, LiW, YinX, DongL. Inhibition of NCAPG expression inactivates the Wnt/β-catenin signal to suppresses endometrial cancer cell growth in vitro. Environ. Toxicol.36(12), 2512–2520 (2021).
  • Pan JH , ZhouH, CooperLet al. LAYN is a prognostic biomarker and correlated with immune infiltrates in gastric and colon cancers. Front. Immunol.10, 6 (2019).
  • Shen H , WangZ, RenSet al. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC). Int. Immunopharmacol.81, 106222 (2020).
  • Zhao R , PengC, SongCet al. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates. Int. Immunopharmacol.87, 106828 (2020).
  • Chen Q , PuN, YinHet al. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer. J. Cell. Mol. Med.24(15), 8674–8686 (2020).
  • Zhang X , WangH, HanYet al. NCAPG induces cell proliferation in cardia adenocarcinoma via PI3K/AKT signaling pathway. Onco Targets Ther.13, 11315–11326 (2020).
  • Xiao Z , HuL, YangLet al. TGFβ2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer. J. Cell. Mol. Med.24(13), 7151–7162 (2020).
  • Zhang X , ZhuM, WangHet al. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial–mesenchymal transition through the Wnt/β-catenin signaling pathway. Gene766, 145163 (2021).
  • Guo X , ZhangY, ZhengLet al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med.24, 978–985 (2018).
  • Desmedt C , SalgadoR, ForniliMet al. Immune infiltration in invasive lobular breast cancer. J. Natl Cancer Inst.110(7), 768–776 (2018).
  • Zhang Q , SuR, ShanC, GaoC, WuP. Non-SMC condensin I complex, subunit G (NCAPG) is a novel mitotic gene required for hepatocellular cancer cell proliferation and migration. Oncol. Res.26(2), 269–276 (2018).
  • Eraso-Pichot A , Brasó-VivesM, GolbanoAet al. GSEA of mouse and human mitochondriomes reveals fatty acid oxidation in astrocytes. Glia66(8), 1724–1735 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.